Cargando…
Plant-Based Vaccines: Antigen Design, Diversity, and Strategies for High Level Production
Vaccines for human use have conventionally been developed by the production of (1) microbial pathogens in eggs or mammalian cells that are then inactivated, or (2) by the production of pathogen proteins in mammalian and insect cells that are purified for vaccine formulation, as well as, more recentl...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782010/ https://www.ncbi.nlm.nih.gov/pubmed/35062761 http://dx.doi.org/10.3390/vaccines10010100 |